NYSE:CO - New York Stock Exchange, Inc. - KYG393421030 - Common Stock - Currency: USD
2.9876
+0.77 (+34.58%)
The current stock price of CO is 2.9876 USD. In the past month the price increased by 34.58%. In the past year, price decreased by -35.19%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
CI | THE CIGNA GROUP | 10.97 | 82.08B | ||
CVS | CVS HEALTH CORP | 11.71 | 79.88B | ||
LH | LABCORP HOLDINGS INC | 17.15 | 20.84B | ||
DGX | QUEST DIAGNOSTICS INC | 19.1 | 19.12B | ||
FMS | FRESENIUS MEDICAL CARE-ADR | 13.74 | 13.55B | ||
BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 148.77 | 12.18B | ||
DVA | DAVITA INC | 14.99 | 11.68B | ||
HIMS | HIMS & HERS HEALTH INC | 112 | 10.77B | ||
CHE | CHEMED CORP | 23.84 | 8.18B | ||
CRVL | CORVEL CORP | 25.97 | 5.57B | ||
OPCH | OPTION CARE HEALTH INC | 26.89 | 5.45B | ||
GH | GUARDANT HEALTH INC | N/A | 5.30B |
Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. The company employs 1,202 full-time employees The company went IPO on 2009-11-19. The firm and its subsidiaries are principally engaged in the provision of umbilical cord blood storage and ancillary services in the People's Republic of China. The company provides cord blood testing, processing and storage services under the direction of subscribers for a cord blood processing fee and a storage fee. The company also tests, processes and stores donated cord blood, and provides matching services to the public for a fee. The firm provides cord blood processing and storage services for expectant parents interested in capturing the opportunities made available by evolving medical treatments and technologies, such as cord blood transplants. The company also preserves cord blood units donated by the public; provides matching services on such donated units, and delivers matching units to patients in need of transplants.
Global Cord Blood Corporation
48 Fl., Bank Of China Tower
HK
CEO: Ting Zheng
Employees: 1202
Company Website: http://www.globalcordbloodcorp.com/
Phone: 85236058180.0
The current stock price of CO is 2.9876 USD. The price increased by 34.58% in the last trading session.
The exchange symbol of Global Cord Blood Corporation is CO and it is listed on the New York Stock Exchange, Inc. exchange.
CO stock is listed on the New York Stock Exchange, Inc. exchange.
Global Cord Blood Corporation (CO) has a market capitalization of 400.08M USD. This makes CO a Small Cap stock.
Global Cord Blood Corporation (CO) currently has 1202 employees.
Global Cord Blood Corporation (CO) has a resistance level at 3. Check the full technical report for a detailed analysis of CO support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
CO does not pay a dividend.
Global Cord Blood Corporation (CO) will report earnings on 2022-10-11, after the market close.
The PE ratio for Global Cord Blood Corporation (CO) is 5.15. This is based on the reported non-GAAP earnings per share of 0.58 and the current share price of 2.9876 USD. Check the full fundamental report for a full analysis of the valuation metrics for CO.
ChartMill assigns a technical rating of 4 / 10 to CO. When comparing the yearly performance of all stocks, CO is a bad performer in the overall market: 68.4% of all stocks are doing better.
ChartMill assigns a fundamental rating of 6 / 10 to CO. CO is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average.
Over the last trailing twelve months CO reported a non-GAAP Earnings per Share(EPS) of 0.58. The EPS decreased by -1.41% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 40.3% | ||
ROA | 5.87% | ||
ROE | 10.27% | ||
Debt/Equity | 0 |
ChartMill assigns a Buy % Consensus number of 84% to CO. The Buy consensus is the average rating of analysts ratings from 9 analysts.